Phenytoin-induced Gingival Overgrowth: A Case Report

Jump To References Section

Authors

  • Antush Mittal
     Department of Periodontics, Modern Dental College and Research Centre, Gandhi Nagar, Airport Road, Indore, M.P. ,IN
  • Shoyab Khan
     Department of Periodontics, Modern Dental College and Research Centre, Gandhi Nagar, Airport Road, Indore, M.P. ,IN

Keywords:

Phenytoin, Gingival Enlargement, Anticonvulsants, Drug-induced Gingival Overgrowth
Periodontics

Abstract

Drug-induced gingival enlargement manifests as an abnormal growth of the gingiva due to an adverse drug reaction in patients treated with anticonvulsants, immunosuppressants and calcium channel blockers. The enlargement affects the normal oral hygiene practice and may even interfere with masticatory functions. It may gradually becomes a source of pain and could lead to disfigurement and cosmetic problem, interfere with mastication and speech, impede effective tooth cleaning or force the teeth out of alignment. It is a serious concern for both the patient and the clinician due to unaesthetic appearance and formation of new niches for Periodonto-pathogenic bacteria. Among the anticonvulsants, Phenytoin has most frequently been described to be associated with Gingival Enlargement. This case report presents gingival hyperplasia as a side effect of Phenytoin use in a 17-year-old female patient on this drug for the last 1 year.

Downloads

Published

2018-11-09

How to Cite

Mittal, A., & Khan, S. (2018). Phenytoin-induced Gingival Overgrowth: A Case Report. Journal of Pierre Fauchard Academy (India Section), 27(3), 102–105. Retrieved from https://informaticsjournals.co.in/index.php/jpfa/article/view/22652

Issue

Volume 27, Issue 3, September 2013

Section

Case Report

License

All the articles published in JPFA are distributed under a creative commons license. The journal allows the author(s) to hold the copyright of their work (all usages allowed except for commercial purpose).

 

References

Marshal RI, Bartold PM. Medication induced gingival overgrowth. Oral Dis. 1998;4:130-151.

Femin AC, Eva LH. Gingival enlargement. In: Newman, Takei, Carranza, Klokkevold, eds. Carranza's Clinical Periodontology. 10th ed. St. Louis: Saunders Publishers; 2006:373-390.

Tvakada K, Sugiyama H, Umezawa K, et al. The subgingival microflora in phenytoin-induced gingival hyperplasia. J Periodont Res. 2003;38:477-481.

Seymour RA, Ellis JS, Thompson JM, et al. Amlodipine induced gingival overgrowth. J Clin Periodontol. 1994;21:281-283.

Jorgensen MG. Prevalence of amlodipine-related gingival hyperplasia. J Periodontol. 1997;68:676-678.

Seymour RA, Thompson JM, Ellis JS. The pathogenesis of drug induced gingival overgrowth. J Clin Periodontol. 1996;23:165-175.

Merritt H, Putman T. Sodium diphenyl hydantoinate in the treatment of convulsive disorders. JAMA. 1938;111:1068-1103.

Thomason JM, Seymour RA, Rawlins MD. Incidence and severity of phenytoin induced gingival overgrowth in epileptic patient's in general medical practice. Community Dent Oral Epidemiol. 1992;20:288-291.

Majola MP, McFayden ML, Connoly C, et al. Factors influencing phenytoin induced gingival enlargement. J Clin Periodontol. 2000;27:506-512.

Shafer WG. Effect of Dilantin sodium on various cell lines in tissue culture. Proc Soc Exp Biol Med. 1961;108:694.

Nyska A, Shemesh M, Tal H, et al. Gingival hyperplasia induced by calcium-channel blockers: mode of action. Med Hypotheses. 1994;43:115-118.

Barclay S, Thomason JM, Idle JR, et al. The incidence and severity of nifedipine induced gingival overgrowth. J Clin Periodontol. 1992;19:311-314.